A premier cancer treatment and research institution in Manhattan
Saphier has been nominated to serve as surgeon general. She is navigating questions about vaccine policy, credentials, and potential conflicts of interest as lawmakers scrutinize her readiness to lead public health messaging.
Drugmakers Moderna and Merck have released Phase 3 results showing their personalised mRNA vaccine, intismeran, plus the immunotherapy pembrolizumab (Keytruda) has reduced the two‑year risk of melanoma recurrence or death by 42% and distant metastasis or death by 38% in a trial of about 1,137 patients. Data were released after partial results leaked and will be presented at ESMO.